| Limited-duration Teclistamab (NCT05932680) | Abramson Cancer Center at Penn Medicine | 2023-07-05 |
| Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease (NCT05506488) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-07-05 |
| Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery (NCT05929664) | Thomas Jefferson University | 2023-07-05 |
| A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer (NCT05911958) | Henan Cancer Hospital | 2023-07-05 |
| Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer (NCT05771584) | Aston Sci. Inc. | 2023-07-04 |
| Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS (NCT05947747) | Nano24med | 2023-07-04 |
| Efficacy and Mechanism of Repetitive Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorders (NCT05927792) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2023-07-04 |
| Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC (NCT06424821) | Shanghai Pulmonary Hospital, Shanghai, China | 2023-07-04 |
| Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease (NCT05948761) | Radboud University Medical Center | 2023-07-04 |
| A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors (NCT05991583) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2023-07-03 |
| Fitness After Stroke Trial (NCT05936008) | University of Kansas Medical Center | 2023-07-03 |
| An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (NCT05757570) | Alpine Immune Sciences, Inc. | 2023-07-03 |
| Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn) (NCT05907291) | Crinetics Pharmaceuticals Inc. | 2023-07-03 |
| Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder (NCT05549258) | Amgen | 2023-07-03 |
| Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome (NCT06254391) | Medical University of Warsaw | 2023-07-03 |
| A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Treatment With a Combination of Sotorasib and Panitumumab (NCT05993455) | Korea University Anam Hospital | 2023-07-03 |
| Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC (NCT06955156) | QIAO LI | 2023-07-03 |
| Evaluate the Efficacy and Safety of Different Doses of Edaravone Dexborneol Concentrated Solution for Injection Combined With Conventional Medical Therapy in the Treatment of Patients With Cerebral Hemorrhage (NCT05953103) | Simcere Pharmaceutical Co., Ltd | 2023-07-03 |
| (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma (NCT05907954) | IDEAYA Biosciences | 2023-07-03 |
| ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder (NCT05749055) | Engrail Therapeutics INC | 2023-07-03 |
| Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults (NCT05933642) | University of Malaya | 2023-07-02 |
| Modified Thoracoabdominal Nerves Block Through Perichondrial Approach: a New Strategy With a Wide Range of Utilization in Laparoscopic Gynecological Surgeries. (NCT06039423) | Alexandria University | 2023-07-02 |
| Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® (NCT05900050) | Genfit | 2023-07-02 |
| Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study (NCT06037239) | Peking Union Medical College Hospital | 2023-07-01 |
| An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2) (NCT05928780) | Fudan University | 2023-07-01 |
| Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab (NCT05928897) | Xiangya Hospital of Central South University | 2023-07-01 |
| Vit D and Peripheral Neuropathy in Taxane Naive Patients (NCT05852496) | Assiut University | 2023-07-01 |
| Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma (NCT05908916) | Yonsei University | 2023-07-01 |
| Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer (NCT05194293) | Academic and Community Cancer Research United | 2023-07-01 |
| "Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease" (NCT05874505) | Assistance Publique - Hôpitaux de Paris | 2023-07-01 |
| Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma (NCT04797884) | THERABIONIC INC. | 2023-07-01 |
| Effect of Metformin and Combination of Olive Oil Plus Nutritional Supplements on Inflammatory Markers IL-6 and IL-8 in PCOS. (NCT05952349) | Khyber Medical University Peshawar | 2023-07-01 |
| 68-Ga-FAPI PET Imaging in Malignancy (NCT04023240) | Stanford University | 2023-07-01 |
| Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer (NCT06014372) | Sun Yat-sen University | 2023-07-01 |
| Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM (NCT05909826) | Dong-A University Hospital | 2023-07-01 |
| Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease (NCT06478134) | University of Seville | 2023-07-01 |
| Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study (NCT07491159) | Tianjin Medical University Cancer Institute and Hospital | 2023-07-01 |
| GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients (NCT04987996) | Providence Health & Services | 2023-07-01 |
| Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (NCT03850730) | Cure HHT | 2023-07-01 |
| Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC (NCT05910034) | Fudan University | 2023-07-01 |
| PET Synaptogenesis After Psilocybin In DEpression Recovery (NCT05601648) | Washington University School of Medicine | 2023-07-01 |
| Effects of Sitagliptin in Relatives of T1D Patients (NCT05219409) | University of Milan | 2023-07-01 |
| Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia (NCT05929248) | Guanmin Gao | 2023-07-01 |
| Endovascular Stroke Treatment And Reteplase Protocol (NCT05900674) | Zeenat Qureshi Stroke Institute | 2023-07-01 |
| Rescue Pharmacotherapy for OSA (NCT05293600) | Brigham and Women's Hospital | 2023-07-01 |
| Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas (NCT05926206) | University of Michigan Rogel Cancer Center | 2023-07-01 |
| A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies (NCT05932173) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-07-01 |
| Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus (NCT07111325) | Shanghai 6th People's Hospital | 2023-07-01 |
| Solidarity/Tokomeza Ebola Trial (NCT05909358) | Makerere University | 2023-07-01 |
| Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer (NCT05751265) | Fujian Cancer Hospital | 2023-07-01 |
| Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors (NCT05920863) | Zhejiang Cancer Hospital | 2023-07-01 |
| Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response (NCT05371860) | Armando Giuliano | 2023-07-01 |
| CMV CTLs in Neonates With CMV Infection (NCT05564598) | New York Medical College | 2023-07-01 |
| Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk (NCT05753436) | Ain Shams University | 2023-07-01 |
| Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases (NCT05866432) | Medical University of Vienna | 2023-07-01 |
| "Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. (NCT05914584) | Nantes University Hospital | 2023-07-01 |
| Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics (NCT05722782) | University of Monastir | 2023-07-01 |
| Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT (NCT05623267) | Sun Yat-sen University | 2023-07-01 |
| Precise Infliximab Exposure and Pharmacodynamic Control (NCT05660746) | Children's Hospital Medical Center, Cincinnati | 2023-07-01 |
| Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study (NCT05901324) | National Taiwan University Hospital | 2023-07-01 |
| Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer (NCT05772377) | The First Affiliated Hospital with Nanjing Medical University | 2023-07-01 |
| To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. (NCT05948449) | Sichuan University | 2023-07-01 |
| Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC (NCT05970705) | Fudan University | 2023-07-01 |
| Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia (NCT05944211) | RenJi Hospital | 2023-07-01 |
| Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer (NCT06051851) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2023-07-01 |
| Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma (NCT05924997) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-07-01 |
| Fulvestrant + Neratinib In Breast Cancer (NCT04901299) | Massachusetts General Hospital | 2023-07-01 |
| CIETAI and Sequential Radiotherapy in Squamous Lung Cancer (NCT05892237) | Dong Wang | 2023-07-01 |
| Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer (NCT05978609) | West China Hospital | 2023-07-01 |
| SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor (NCT05436639) | Sparrow Pharmaceuticals | 2023-07-01 |
| Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis (NCT05101447) | Children's Hospital Medical Center, Cincinnati | 2023-07-01 |
| Combined Treatment of Treated Bile Duct Cancer (NCT05911425) | Zhejiang Cancer Hospital | 2023-07-01 |
| Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL (NCT06468943) | The First Affiliated Hospital of Soochow University | 2023-07-01 |
| Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma (NCT05903456) | Zhejiang Cancer Hospital | 2023-07-01 |
| A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity (NCT05997862) | University of Southern Mississippi | 2023-07-01 |
| Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study. (NCT05864508) | University Hospital, Toulouse | 2023-07-01 |
| Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma (NCT05909098) | Xiangyang No.1 People's Hospital | 2023-07-01 |
| Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery (NCT05950152) | Beijing Tide Pharmaceutical Co., Ltd | 2023-07-01 |
| Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma (NCT05952128) | Sun Yat-sen University | 2023-07-01 |
| Opioid Free Anesthesia in Abdominal Laparoscopic Surgery (NCT06394375) | Indonesia University | 2023-07-01 |
| A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL (NCT05931757) | The First Affiliated Hospital of Soochow University | 2023-07-01 |
| Effects of Pioglitazone in Calcific Aortic Valve Disease (NCT05875675) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-07-01 |
| Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer (NCT05932264) | Sun Yat-sen University | 2023-07-01 |
| PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC (NCT06186609) | Affiliated Hospital of Nantong University | 2023-07-01 |
| Folic Acid Supplementation in Calcific Aortic Valve Disease (NCT05861648) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-07-01 |
| Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer (NCT05915442) | Catherine Spina | 2023-07-01 |
| Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation (NCT05912205) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-07-01 |
| Ruxolitinib as GVHD Prophylaxis in AA Patients (NCT05914714) | Institute of Hematology & Blood Diseases Hospital, China | 2023-07-01 |
| Pediatric Postoperative Analgesia Herniorrhaphy Study (NCT03922048) | Heron Therapeutics | 2023-07-01 |
| Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders (NCT05838560) | Washington University School of Medicine | 2023-07-01 |
| Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) (NCT05258422) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2023-07-01 |
| Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients (NCT05947825) | Tianjin Medical University Cancer Institute and Hospital | 2023-07-01 |
| The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes (NCT05925504) | Institute of Hematology & Blood Diseases Hospital, China | 2023-07-01 |
| Effect Of Patient Awareness About Possibility Of Occurrence Of Pain During Propofol Injection On The Rate Of Incidence And Severity Of Pain During Injection . (NCT05886972) | Beni-Suef University | 2023-07-01 |
| Venetoclax Combined With Azactidine in the Treatment of ALAL (NCT05901974) | Sheng-Li Xue, MD | 2023-07-01 |
| Turmeric, Black Seeds, Flaxseed and Medicago Sativa in Knee Osteoarthritis (NCT05723458) | Tabriz University of Medical Sciences | 2023-07-01 |
| Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer (NCT05900921) | Sichuan University | 2023-07-01 |
| Does Psilocybin Require Psychedelic Effects to Treat Depression? (NCT05710237) | Centre for Addiction and Mental Health | 2023-07-01 |
| Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial (NCT05891080) | Shanghai Pulmonary Hospital, Shanghai, China | 2023-07-01 |
| Efficacy of Roflumilast in Prevention of Peripheral Neuropathy (NCT05884281) | Mansoura University | 2023-07-01 |